MS Dec 2025 72.500 call
| Previous Close | 30.40 |
| Open | 30.40 |
| Bid | 27.35 |
| Ask | 29.10 |
| Strike | 72.50 |
| Expire Date | 2025-12-19 |
| Day's Range | 30.40 - 30.40 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 17 |
BloombergBicara Therapeutics Picks Morgan Stanley For IPO of Up to $150 Million
(Bloomberg) -- Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as the market for first-time share sales is showing signs of normalizing. Most Read from BloombergGavin Newsom Is Ready for the Biden EmergencyThe Question on Democrats’ Minds: How to Replace Biden?Biden’s Disastrous Debate Accelerates Doubts Over CandidacyPanicked Emails, Gallows Humor: The Aftermath of Biden's Debate DisasterSupreme Court Overturns Chevron
- Business Wire
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
NEW YORK, June 28, 2024--Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2024.
Barrons.comWeek’s Best: ETFs Win Popularity Contest
Morgan Stanley hit with cash-sweep suit. Morgan Stanley pays an interest rate of as little as 0.01% on customers’ uninvested cash in its default bank sweep program. Morgan Stanley declined to comment on the case.
